Royal Surrey staff celebrate radiotherapy treatment for 500th rectal cancer patient
The Royal Surrey NHS Foundation Trust celebrates a milestone, having successfully treated its 500th rectal cancer patient with radiotherapy.
Targeting MYCN and MDM2 offers new hope for cancer therapy
Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.
Moffitt Cancer Center Announces New Proton Therapy Treatment
Moffitt Cancer Center has introduced a new proton therapy treatment, offering advanced options for cancer patients.
Clinical Studies Conducted at Florida Cancer Specialists & Research Institute Expanding Treatment Options and Improving Outcomes for Patients with Gastrointestinal and Genitourinary Cancers
/PRNewswire/ — Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) is expanding treatment options and contributing to…
Navigating nutrition during cancer treatment: A dietitian's advice
During cancer treatment, our bodies require optimal nourishment, so eating well is especially important. Unfortunately, the treatments themselves—including chemotherapy and radiation—can interfere with appetite and digestion, making it harder to consistently eat healthy foods or even eat much at all. Filling your fridge and pantry with a variety of foods before treatment begins and being […]
New Insights into Cancer Treatment Emerge
Recent studies have provided new insights into cancer treatment, potentially paving the way for more effective therapies.
Roche’s Itovebi Rivals Novartis and AZ, Bolsters Its Benefits Profile with Overall Survival Win
Roche’s cancer drug Itovebi has demonstrated improved overall survival rates, positioning it as a strong competitor against treatments from Novartis and AstraZeneca.
Study highlights new target and potential therapy for treatment-resistant cancers
University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant cancers by targeting a specific protein modification, according to a study published in the International Journal of Biological Sciences.
From COVID-19 testing to a breakthrough in cancer treatment monitoring
Innovations originally developed for COVID-19 testing are now being applied to monitor cancer treatments more effectively.
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy regimen, according to results from the Phase III BREAKWATER trial led by researchers at The University of Texas MD Anderson Cancer Center.
Researchers find a way to stop harmful cells after cancer treatment
Researchers from the University of Barcelona describe a mechanism for eliminating harmful cells from cancer treatment
Cancer protein discovery reveals new treatment target
Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not only improves our understanding of why this type of cancer can be aggressive in some people, but it also highlights a potential treatment target.
